Accumulating evidence points to a key role of mitochondrial dysfunction in the pathophysiology and progression of NAFLD, possibly caused by increased mitochondrial β-oxidation of fatty acids in insulin-resistant states [28,29] and by impaired adaptation of hepatic mitochondrial function in NAFLD [30]. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.